Hybio Pharmaceutical Statistics

Total Valuation

SHE:300199 has a market cap or net worth of CNY 15.42 billion. The enterprise value is 17.23 billion.

Market Cap	15.42B
Enterprise Value	17.23B

Important Dates

The next confirmed earnings date is Saturday, April 25, 2026.

Earnings Date	Apr 25, 2026
Ex-Dividend Date	n/a

Share Statistics

SHE:300199 has 883.24 million shares outstanding. The number of shares has increased by 2.68% in one year.

Current Share Class	883.24M
Shares Outstanding	883.24M
Shares Change (YoY)	+2.68%
Shares Change (QoQ)	-9.28%
Owned by Insiders (%)	24.44%
Owned by Institutions (%)	3.56%
Float	643.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	17.17
PB Ratio	23.15
P/TBV Ratio	41.04
P/FCF Ratio	119.65
P/OCF Ratio	44.40
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 67.13, with an EV/FCF ratio of 133.67.

EV / Earnings	-255.24
EV / Sales	19.18
EV / EBITDA	67.13
EV / EBIT	153.82
EV / FCF	133.67

Financial Position

The company has a current ratio of 0.37, with a Debt / Equity ratio of 2.90.

Current Ratio	0.37
Quick Ratio	0.16
Debt / Equity	2.90
Debt / EBITDA	7.52
Debt / FCF	14.97
Interest Coverage	1.12

Financial Efficiency

Return on equity (ROE) is -10.67% and return on invested capital (ROIC) is 4.59%.

Return on Equity (ROE)	-10.67%
Return on Assets (ROA)	2.23%
Return on Invested Capital (ROIC)	4.59%
Return on Capital Employed (ROCE)	6.77%
Weighted Average Cost of Capital (WACC)	8.46%
Revenue Per Employee	867,726
Profits Per Employee	-65,214
Employee Count	1,035
Asset Turnover	0.29
Inventory Turnover	1.50

Taxes

In the past 12 months, SHE:300199 has paid 27.30 million in taxes.

Income Tax	27.30M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +41.80% in the last 52 weeks. The beta is 0.86, so SHE:300199's price volatility has been lower than the market average.

Beta (5Y)	0.86
52-Week Price Change	+41.80%
50-Day Moving Average	18.83
200-Day Moving Average	19.84
Relative Strength Index (RSI)	39.11
Average Volume (20 Days)	19,785,186

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:300199 had revenue of CNY 898.10 million and -67.50 million in losses. Loss per share was -0.08.

Revenue	898.10M
Gross Profit	494.03M
Operating Income	112.00M
Pretax Income	-47.20M
Net Income	-67.50M
EBITDA	255.80M
EBIT	112.00M
Loss Per Share	-0.08

Full Income Statement

Balance Sheet

The company has 140.42 million in cash and 1.93 billion in debt, giving a net cash position of -1.79 billion or -2.03 per share.

Cash & Cash Equivalents	140.42M
Total Debt	1.93B
Net Cash	-1.79B
Net Cash Per Share	-2.03
Equity (Book Value)	666.08M
Book Value Per Share	0.73
Working Capital	-951.59M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 347.34 million and capital expenditures -218.45 million, giving a free cash flow of 128.89 million.

Operating Cash Flow	347.34M
Capital Expenditures	-218.45M
Free Cash Flow	128.89M
FCF Per Share	0.15

Full Cash Flow Statement

Margins

Gross margin is 55.01%, with operating and profit margins of 12.47% and -7.52%.

Gross Margin	55.01%
Operating Margin	12.47%
Pretax Margin	-5.26%
Profit Margin	-7.52%
EBITDA Margin	28.48%
EBIT Margin	12.47%
FCF Margin	14.35%

Dividends & Yields

SHE:300199 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.68%
Shareholder Yield	-2.68%
Earnings Yield	-0.44%
FCF Yield	0.84%

Stock Splits

The last stock split was on April 14, 2015. It was a forward split with a ratio of 2.

Last Split Date	Apr 14, 2015
Split Type	Forward
Split Ratio	2

Scores

SHE:300199 has an Altman Z-Score of 2.64 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.64
Piotroski F-Score	6